Cargando…
Poncirin Inhibits Osteoclast Differentiation and Bone Loss through Down-Regulation of NFATc1 In Vitro and In Vivo
Activation of osteoclast and inactivation of osteoblast result in loss of bone mass with bone resorption, leading to the pathological progression of osteoporosis. The receptor activator of NF-κB ligand (RANKL) is a member of the TNF superfamily, and is a key mediator of osteoclast differentiation. A...
Autores principales: | Chun, Kwang-Hoon, Jin, Hyun Chul, Kang, Ki Sung, Chang, Tong-Shin, Hwang, Gwi Seo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Korean Society of Applied Pharmacology
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7327144/ https://www.ncbi.nlm.nih.gov/pubmed/31500404 http://dx.doi.org/10.4062/biomolther.2018.216 |
Ejemplares similares
-
Betulin Suppresses Osteoclast Formation via Down-Regulating NFATc1
por: Kim, Kwang-Jin, et al.
Publicado: (2018) -
Suppression Effect of Astaxanthin on Osteoclast Formation In Vitro and Bone Loss In Vivo
por: Hwang, Yun-Ho, et al.
Publicado: (2018) -
Regulation of NFATc1 in Osteoclast Differentiation
por: Kim, Jung Ha, et al.
Publicado: (2014) -
Nitidine chloride prevents OVX-induced bone loss via suppressing NFATc1-mediated osteoclast differentiation
por: Liu, Qian, et al.
Publicado: (2016) -
Protective effect of Korean Red Ginseng against glucocorticoid-induced osteoporosis in vitro and in vivo
por: Kim, Jinhee, et al.
Publicado: (2014)